1. miR-135b Plays a Neuroprotective Role by Targeting GSK3β in MPP+-Intoxicated SH-SY5Y Cells
    Jianlei Zhang et al, 2017, Disease Markers CrossRef
  2. microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer
    Siranjeevi Nagaraj et al, 2018, Ageing Research Reviews CrossRef
  3. The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease.
    Yanfang Zhao et al, 2019, Aging Dis CrossRef
  4. MicroRNAs in Alzheimer’s Disease
    Mengli Wang et al, 2019, Front. Genet. CrossRef
  5. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease
    Soraya Herrera-Espejo et al, 2019, Mol Neurobiol CrossRef
  6. A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
    P. Hemachandra Reddy et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  7. MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease.
    P H Reddy et al, 2017, Prog Mol Biol Transl Sci CrossRef
  8. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.
    Mark J Millan, 0 CrossRef
  9. Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets
    J. Weldon Furr et al, 2019, Neuromol Med CrossRef
  10. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
    M.M.J. van den Berg et al, 2019, Progress in Neurobiology CrossRef
  11. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties
    Nipun Chopra et al, 2020, Mol Psychiatry CrossRef
  12. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells
    Nan Zhang et al, 2020, NeuroReport CrossRef
  13. GSK3 and miRNA in neural tissue: From brain development to neurodegenerative diseases
    Agnieszka Gizak et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  14. Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson’s disease by upregulating microRNA-34b-5p and downregulating BACE1
    Yanhong Li et al, 2020, Cell Cycle CrossRef
  15. miR-135b-dependent down-regulation of S100B promotes neural stem cell differentiation in a hypoxia/ischemia-induced cerebral palsy rat model
    Linbao Wen et al, 2020, American Journal of Physiology-Cell Physiology CrossRef
  16. Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
    Alex Cleber Improta-Caria et al, 2020, IJMS CrossRef
  17. MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
    Wei Wei et al, 2020, Front. Mol. Neurosci. CrossRef
  18. microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic Perspective
    Dolores Siedlecki-Wullich et al, 2021, Cells CrossRef
  19. Epigenetics of Alzheimer’s Disease
    Matea Nikolac Perkovic et al, 2021, Biomolecules CrossRef
  20. The crosstalk of HDAC3, microRNA-18a and ADRB3 in the progression of heart failure
    Jingtao Na et al, 2021, Cell Biosci CrossRef
  21. The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease
    Mohammad Samadian et al, 2021, Front. Aging Neurosci. CrossRef
  22. In silico Analysis of Polymorphisms in microRNAs Deregulated in Alzheimer Disease
    Mahta Moraghebi et al, 2021, Front. Neurosci. CrossRef
  23. MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer’s disease
    Seyedeh Nazanin Hajjari et al, 2021, Neuroscience CrossRef
  24. microRNA‐125b and its downstream Smurf1/KLF2/ATF2 axis as important promoters on neurological function recovery in rats with spinal cord injury
    Kunchi Zhao et al, 2021, J Cell Mol Med CrossRef
  25. Protective role of ABCA1 in ischemic preconditioning is mediated by downregulation of miR-33-5p and miR-135-5p
    Hye Youn Sung et al, 2021, Sci Rep CrossRef
  26. RNA Dynamics in Alzheimer’s Disease
    Agnieszka Rybak-Wolf et al, 2021, Molecules CrossRef
  27. MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities
    Nermeen Z. Abuelezz et al, 2021, Front. Aging Neurosci. CrossRef
  28. The Clinical Significance of miR-135b-5p and Its Role in the Proliferation and Apoptosis of Hippocampus Neurons in Children with Temporal Lobe Epilepsy
    Ruixiang Li et al, 2020, Dev Neurosci CrossRef
  29. Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training
    Ricardo Augusto Leoni De Sousa et al, 2022, Metab Brain Dis CrossRef
  30. Age‐related miRNAs dysregulation and abnormal BACE1 expression following Pb exposure in adolescent mice
    Ruike Wang et al, 2022, Environmental Toxicology CrossRef
  31. null
    Heena Chauhan et al, 2022 CrossRef
  32. MicroRNAs in Learning and Memory and Their Impact on Alzheimer’s Disease
    I-Fang Wang et al, 2022, Biomedicines CrossRef
  33. MicroRNAs: protective regulators for neuron growth and development
    Zhi-Xuan Ma et al, 2023, Neural Regen Res CrossRef
  34. A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
    Rima Hajjo et al, 2022, Diagnostics CrossRef
  35. Role of non‑coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)
    Katerina Pierouli et al, 2022, Int J Mol Med CrossRef
  36. Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning.
    Sze Chung Yuen et al, 2021, Alzheimers Res Ther CrossRef
  37. null
    Shalini Swaroop et al, 2023 CrossRef
  38. null
    Mahima Raval et al, 2023 CrossRef
  39. MicroRNA expression in extracellular vesicles as a novel blood‐based biomarker for Alzheimer's disease
    Ashish Kumar et al, 2023, Alzheimer's & Dementia CrossRef
  40. Identification of Key MicroRNAs Regulating ELOVL6 and Glioblastoma Tumorigenesis
    Nurani Istiqamah et al, 2022, SSRN Journal CrossRef
  41. Integrated gene expression profiling and functional enrichment analyses to discover biomarkers and pathways associated with Guillain-Barré syndrome and autism spectrum disorder to identify new therapeutic targets
    Rizone Al Hasib et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
  42. Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective
    Mounisha Bandakinda et al, 2023, International Journal of Biological Macromolecules CrossRef
  43. Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
    Long Wang et al, 2023, IJMS CrossRef
  44. Alzheimer’s Disease-Related Epigenetic Changes: Novel Therapeutic Targets
    Alireza Paniri et al, 2024, Mol Neurobiol CrossRef
  45. null
    Divya Adiga et al, 2023 CrossRef
  46. miR-135b: an emerging player in cardio-cerebrovascular diseases
    Yingchun Shao et al, 2024, Journal of Pharmaceutical Analysis CrossRef
  47. MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review
    Hafiz Muhammad Husnain Azam et al, 2024, Front. Mol. Neurosci. CrossRef